Related Experiment Videos
Malignant bone pain: pathophysiology and treatments.
1Rehabilitation, Pain Therapy and Palliative Care Division, National Cancer Institute, via Venezian, 1, Milano 20133, Italy. ripamonti@istitutotumori.mi.it
Current Review of Pain
|September 22, 2000
Summary
Metastatic bone pain, common in cancer patients, often requires multidisciplinary treatment. Bisphosphonates show promise, but neuroinvasive techniques remain debated for managing this pain.
Area of Science:
- Oncology
- Pain Management
- Skeletal Metastasis
Background:
- Bone metastases are a frequent cause of pain in cancer patients.
- Pain mechanisms include somatic, neuropathic, and visceral components.
- Early signs of widespread neoplastic disease often involve bone lesions.
Purpose of the Study:
- To review current and emerging treatments for metastatic bone pain.
- To discuss the role of bisphosphonates and neuroinvasive techniques.
- To emphasize personalized therapy selection based on patient condition.
Main Methods:
- Review of conventional multidisciplinary therapies (radiotherapy, systemic treatments, analgesics).
- Inclusion of recent studies on bisphosphonates for pain and skeletal complications.
- Discussion of the debated role of neuroinvasive techniques.
Main Results:
- Conventional treatments may not always adequately manage pain.
- Bisphosphonates are indicated for pain treatment and skeletal complication prevention.
- The efficacy and role of neuroinvasive techniques require further investigation.
Conclusions:
- Metastatic bone pain management is complex and requires tailored approaches.
- Patient factors like life expectancy and quality of life are crucial for therapy choice.
- A multidisciplinary approach, potentially including novel therapies, is essential.